Aeterna Zentaris (AEZS) Says it Plans to Continue to Focus on Oncology
Tweet Send to a Friend
Aeterna Zentaris Inc. (NASDAQ: AEZS) today affirmed its focus on targeted oncologic therapies during the 2016 J.P. Morgan Healthcare Conference ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
